Dr. Walid Dridi joins Agiomix Medical Board

Press Release

June 2019

Dubai, UAE,  – Agiomix, the next generation genomics company announced that Dr. Walid Dridi has joined its Medical Board as of June 2019.

“As part of Agiomix’s strategy to attract talented specialists to join its team, we are glad to announce that Dr.Walid Dridi will join our Board of Medical Directors. Dr. Dridi’s experience in running world-class genomics service laboratories will add a wealth to Agiomix capabilities and standards, and his background in cytogenetics will allow Agiomix to offer detailed and comprehensive medical reports to patients and partner laboratories across the region that match the industry’s highest standards”, said Dr. John Clarkson, Board Director of Agiomix.

Dr. Dridi brings 25 years of experience in research and clinical genetics, he heads the Cytogenetics Department of Pathology and Laboratory Medicine at King Fahad Specialist Hospital, Dammam, KSA. Prior to this he worked with Dr. Hakon the Director of the Center of Applied Genomics at Children Hospital of Philadelphia (CHOP), Philadelphia, USA, his work is focused on genomic data design and analysis, with emphasis on machine and deep-learning methods.

Dr. Dridi holds a Doctorate in Medicine (MD) from Algeria, M.Sc. and PhD in Cellular and Molecular Biology from Laval University, Quebec, Canada and has several publications in renowned medical and scientific journals.

Dr. Dridi said “I’m very happy to join the Medical Board of Agiomix. I believe in the company’s vision and can see the persistent need for its services across the region and I have a clear plan to develop the company’s laboratory practices to match the highest international quality standards, and to place the company amongst the best genomics analysis providers in the world.”

Check out the Press Release https://www.biochannelpartners.com/node/587